Hematologic adverse effects of 2 different polyclonal antilymphocyte preparations in de novo kidney transplant patients

Experimental and Clinical Transplantation

Volumn 8, Issue 2, 2010, Pages

  Rostaing, Lionel ^a,b   Lavayssière, Laurence ^a   Kamar, Nassim ^a  

^a CHU RANGUEIL   (France)

^b CHU PURPAN   (France)

Author keywords

Anemia; Antilymphocyte globulins; Kidney transplantation; Lymphoglobulin; Thrombocytopenia; Thymoglulin

Indexed keywords

CORTICOSTEROID DERIVATIVE; ERYTHROPOIETIN; HEMOGLOBIN; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANEL REACTIVE ANTIBODY; POLYCLONAL ANTIBODY; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD TOXICITY; CADAVER DONOR; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; ERYTHROCYTE TRANSFUSION; FOLLOW UP; GRAFT RECIPIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LEUKOPENIA; NEUTROPENIA; PERITONITIS; PNEUMONIA; POLYMORPHONUCLEAR CELL; PROSPECTIVE STUDY; PYELONEPHRITIS; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE COUNT; SERUM SICKNESS; SIDE EFFECT; THROMBOCYTE COUNT; URINARY TRACT INFECTION;

EID: 77954123600     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Thibaudin D, Alamartine E, de Filippis JP, Diab N, Laurent B, Berthoux F. Advantage of antithymocyte globulin induction in sensitized kidney recipients: a randomized prospective study comparing induction with and without antithymocyte globulin. Nephrol Dial Transplant. 1998;13(3):711-715.
2. Mourad G, Garrigue V, Squifflet JP, et al. Induction versus noninduction in renal transplant recipients with tacrolimus-based immunosuppression. Transplantation. 2001;72(6):1050-1055.
3. Charpentier B, Rostaing L, Berthoux F, et al. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. Transplantation. 2003;75(6):844-851.
4. Büchler M, Hurault de Ligny B, Madec C, Lebranchu Y; French Thymoglobuline Pharmacovigilance Study Group. Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: a 1-yr follow-up of safety and efficacy. Clin Transplant. 2003;17(6):539-545.
5. Mourad G, Rostaing L, Legendre C, Garrigue V, Thervet E, Durand D. Sequential protocols using basiliximab versus antithymocyte globulins in renal-transplant patients receiving mycophenolate mofetil and steroids. Transplantation. 2004;78(4):584-590.
6. Brennan DC, Daller JA, Lake KD, Cibrik D, Del Castillo D; Thymoglobulin Induction Study Group. Rabbit antithymocyte globulin versus basiliximab in renal transplantation. N Engl J Med. 2006;355(19):1967-1977.